Inactive Instrument
Precision Therapeutics Inc Stock Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 87.19M 75.8M 70.55M 64.77M 122M 8.32B 124M 832M 326M 4.14B 327M 320M 13.89B | P/E 2024 |
-0.35x | P/E 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 78.07M 67.86M 63.17M 57.99M 110M 7.45B 111M 745M 292M 3.71B 293M 287M 12.44B | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
94.34% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles L. Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 87.19M | ||
| -1.40% | +2.59% | -1.71% | +11.28% | 48.53B | ||
| -2.41% | -0.90% | +411.96% | +495.33% | 39.87B | ||
| -1.16% | +12.96% | +28.81% | +7.25% | 38.68B | ||
| -1.88% | -3.03% | +5.69% | +53.00% | 35.13B | ||
| -1.74% | +5.12% | +14.44% | +41.77% | 29.79B | ||
| -2.85% | -3.92% | - | - | 16.08B | ||
| -0.21% | -4.04% | +36.40% | +125.75% | 16.11B | ||
| -0.64% | +2.65% | +3.40% | +13.11% | 13.61B | ||
| -1.19% | -1.32% | -1.73% | -34.37% | 12.62B | ||
| Average | -2.10% | +1.05% | +62.16% | +89.14% | 27.82B | |
| Weighted average by Cap. | -1.60% | +2.03% | +79.78% | +108.61% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.62M 1.41M 1.31M 1.21M 2.28M 155M 2.31M 15.49M 6.08M 77.17M 6.1M 5.96M 259M | 125K 109K 101K 93.07K 176K 11.96M 178K 1.19M 469K 5.95M 471K 460K 19.96M |
| Net income | -12.66M -11.01M -10.25M -9.41M -17.77M -1.21B -18.04M -121M -47.41M -602M -47.56M -46.52M -2.02B | -233M -203M -189M -173M -327M -22.25B -332M -2.22B -873M -11.08B -875M -856M -37.15B |
| Net Debt | 1.4M 1.21M 1.13M 1.04M 1.96M 133M 1.99M 13.32M 5.23M 66.36M 5.24M 5.13M 223M | -9.12M -7.93M -7.38M -6.78M -12.8M -871M -13M -87.03M -34.16M -434M -34.27M -33.52M -1.45B |
Employees
-

















